Article
Pseudogene DUXAP10 acts as a diagnostic and prognostic marker and promotes cell…
OncoTargets and Therapy · 2019 · Yue C, Liang C, Ge H, Yan L, Xu Y, Li G, Li P, Wei Z, Wu J
Key facts
| Title | Pseudogene DUXAP10 acts as a diagnostic and prognostic marker and promotes cell proliferation by activating PI3K/AKT pathway in hepatocellular carcinoma |
|---|---|
| First author | Yue C, Liang C, Ge H, Yan L, Xu Y, Li G, Li P, Wei Z, Wu J |
| Journal | OncoTargets and Therapy |
| Published | Jun 11, 2019 |
| DOI | 10.2147/OTT.S210623 |
| Devices mentioned | 201801, 201808, 210623, K852441, K854177, K854178, K854179, K854180, K854181, K854182, K854183, K854184 and 4 more |
| Product codes mentioned | CDT, CEO, CGA, CGX, CHH, CIG, CIS, CIX, CJE, CKA, KLB, KLS and 1 more |
At a glance
- 10–99 FDA submissions mentioned
- 10–99 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1